MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
MedImmune LLC
Philip Ambery; Victoria E Parker; Michael Stumvoll; Maximilian G Posch; Tim Heise; Leona Plum-Moerschel; Lan-Feng Tsai; Darren Robertson; Meena Jain; Marcella Petrone; Cristina Rondinone; Boaz Hirshberg; Lutz Jermutus